We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $3.64B
1-Year Est. Return 83.38%
This Fund
S&P 500
This Quarter Est. Return
+49.74%
1 Year Est. Return
+83.38%
3 Year Est. Return
+239.61%
5 Year Est. Return
+330.19%
10 Year Est. Return
+1,383.86%
AUM
$3.64B
AUM Growth
+$913M
Cap. Flow
+$245M
Cap. Flow %
6.73%
Top 10 Hldgs %
40.93%
Holding
1,250
New
158
Increased
429
Reduced
585
Closed
75

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$72.2M
2
AVGO icon
Broadcom
AVGO
+$27.9M
3
SNDK
Sandisk
SNDK
+$15M
4
AAPL icon
Apple
AAPL
+$13.9M
5
MU icon
Micron Technology
MU
+$12.9M

Sector Composition

Rank Sector Weight
1 Technology 56.05%
2 Healthcare 8.58%
3 Communication Services 8.31%
4 Consumer Discretionary 7.81%
5 Industrials 3.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRH icon
176
CRH
CRH
$62.7B
$2.19M 0.06%
20,436
+9,223
+82% +$1.01M
KHC icon
177
Kraft Heinz
KHC
$29.5B
$2.18M 0.06%
92,300
+4,585
+5% +$106K
CYTK icon
178
Cytokinetics
CYTK
$10.1B
$2.18M 0.06%
25,572
-10,141
-28% -$728K
TWST icon
179
Twist Bioscience
TWST
$8.21B
$2.17M 0.06%
21,095
-21,944
-51% -$1.43M
TRI icon
180
Thomson Reuters
TRI
$45.8B
$2.14M 0.06%
26,262
-1,848
-7% -$161K
KRYS icon
181
Krystal Biotech
KRYS
$10.6B
$2.14M 0.06%
5,770
-3,020
-34% -$902K
APD icon
182
Air Products & Chemicals
APD
$67.1B
$2.14M 0.06%
7,310
+3,231
+79% +$940K
VZ icon
183
Verizon
VZ
$208B
$2.13M 0.06%
50,380
+10,831
+27% +$508K
KYMR icon
184
Kymera Therapeutics
KYMR
$9.76B
$2.12M 0.06%
18,455
-6,688
-27% -$575K
EBAY icon
185
eBay
EBAY
$46B
$2.11M 0.06%
18,917
-1,473
-7% -$157K
C icon
186
Citigroup
C
$231B
$2.11M 0.06%
15,047
-902
-6% -$117K
ALKS icon
187
Alkermes
ALKS
$7.73B
$2.1M 0.06%
40,027
-37,742
-49% -$1.47M
ORKA
188
Oruka Therapeutics
ORKA
$6.13B
$2.09M 0.06%
22,012
+3,676
+20% +$245K
TJX icon
189
TJX Companies
TJX
$145B
$2.09M 0.06%
13,819
-509
-4% -$80.5K
DXCM icon
190
DexCom
DXCM
$33.2B
$2.09M 0.06%
31,013
+1,881
+6% +$125K
TMO icon
191
Thermo Fisher Scientific
TMO
$227B
$2.07M 0.06%
4,138
-61
-1% -$29.3K
ENTG icon
192
Entegris
ENTG
$21.2B
$2.07M 0.06%
11,534
+1,685
+17% +$243K
VMC icon
193
Vulcan Materials
VMC
$34B
$2.07M 0.06%
7,009
+3,218
+85% +$922K
PM icon
194
Philip Morris
PM
$284B
$2.06M 0.06%
11,397
-537
-4% -$93.1K
PRAX icon
195
Praxis Precision Medicines
PRAX
$9.82B
$2.04M 0.06%
6,097
-984
-14% -$311K
ROIV icon
196
Roivant Sciences
ROIV
$25.2B
$2.01M 0.06%
56,751
-19,696
-26% -$582K
TGTX icon
197
TG Therapeutics
TGTX
$8.57B
$2.01M 0.06%
36,513
-39,526
-52% -$1.62M
CVNA icon
198
Carvana
CVNA
$53.7B
$2M 0.06%
30,412
-1,388
-4% -$98.2K
BIDU icon
199
Baidu
BIDU
$33.7B
$2M 0.06%
17,511
-454
-3% -$56.2K
MLM icon
200
Martin Marietta Materials
MLM
$36.6B
$1.98M 0.05%
3,439
+1,726
+101% +$1.02M

Similar funds

Profund Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Profund Advisors held 1,250 positions worth $3.64B, up 34% from $2.72B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Profund Advisors deployed $245M of net new capital in Q2 2026, opening 158 new positions and adding to 429 existing holdings. Its largest new stake was Honeywell Aerospace: 24,902 shares worth $5.51M.

By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 43% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Honeywell, an estimated $5.34M trimmed.

  • Profund Advisors's largest Q2 2026 buy was Honeywell Aerospace: 24,902 shares worth $5.51M.
  • Profund Advisors added most to NVIDIA in Q2 2026, an estimated $72.2M increase.
  • Profund Advisors's biggest Q2 2026 reduction was Honeywell, cutting an estimated $5.34M.
  • Profund Advisors fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $3.27M.
  • Profund Advisors's ten largest holdings make up 41% of its $3.64B portfolio in Q2 2026.
  • Profund Advisors opened 158 new positions and closed 75 in Q2 2026.
  • Profund Advisors's portfolio value rose 34% quarter-over-quarter to $3.64B.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.